Mast cell stabilizing properties of antihistamines

Journal of Investigative Dermatology

Volumn 129, Issue 11, 2009, Pages 2549-2551

  Levi Schaffer, Francesca ^a   Eliashar, Ron ^b  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AZATADINE; BRONCHOCONSTRICTING AGENT; CALCIUM; CALCIUM ION; CETIRIZINE; CYTOCHROME P450; CYTOKINE; DESLORATADINE; EPITHELIAL CELL ADHESION MOLECULE; FEXOFENADINE; G PROTEIN COUPLED RECEPTOR; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H4 RECEPTOR; IMMUNOGLOBULIN E; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 8; IONOPHORE; LEVOCETIRIZINE; LORATADINE; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; MIZOLASTINE; MUSCARINIC RECEPTOR; PADGEM PROTEIN; RANTES; SUBSTANCE P;

ALLERGIC DISEASE; ALLERGIC RHINITIS; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ASTHMA; ATOPIC DERMATITIS; BASOPHIL; CELL ACTIVATION; CELL INFILTRATION; CELL SURVIVAL; CHEMOTAXIS; CONCENTRATION RESPONSE; CONJUNCTIVITIS; CYTOKINE PRODUCTION; DRUG ABSORPTION; DRUG EFFICACY; DRUG MECHANISM; DRUG METABOLISM; DRUG SAFETY; EDEMA; EOSINOPHIL; ERYTHEMA; EXTRACELLULAR CALCIUM; HISTAMINE RELEASE; HUMAN; HUMAN CELL; INFLAMMATION; MAST CELL; NERVE ENDING; NOSE MUCOSA; NOTE; OBSTRUCTION; PRIORITY JOURNAL; PRURITUS; RECEPTOR BINDING; RHINORRHEA; SMOOTH MUSCLE; SNEEZING; TH1 CELL; TH2 CELL; URTICARIA;

EID: 70350046945     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2009.256     Document Type: Note

References (17)

1. Agrawal DK (2004) Anti-inflammatory properties of desloratadine. Clin Exp Allergy 34:1342-1348
2. Assanasen P, Naclerio RM (2000) Antiallergic effects of H1-receptor antagonists. Allergy 55(Suppl 64):17-27
3. Berthon B, Taudou G, Combettes L, Czarlewski W, Carmi-Leroy A, Marchand F et al. (1994) In vitro inhibition, by loratadine and descarboxyethoxyloratadine, of histamine release from human basophils, and of histamine release and intracellular calcium fluxes in rat basophilic leukemia cells (RL-2H3). Biochem Pharmacol 47:789-794
4. Chakravarty N, Nielsen EH (1985) Calmodulin in mast cells and its role in histamine secretion. Agents Actions 16:122-5
5. mast cells and its role in histamine secretion. Agents Actions 16:122-5 de Benedictis FM, de Benedictis D, Canonica GW (2008) New oral H1 antihistamines in children: facts and unmet needs. Allergy 63:1395-1404
6. Frossard N, Strolin-Benedetti M, Purohit A, Pauli G (2008) Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine. Br J Clin Pharmacol 65:172-179
7. Genovese A, Patella V, De Crescenzo G, De Paulis A, Spadaro G, Marone G (1997) Loratadine and desethosylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells. Clin Exp Allergy 27:559-567
8. Klementsson H, Andersson M, Pipkorn U (1990) Allergen-induced increase in nonspecific nasal reactivity is blocked by antihistamines without a clear-cut relationship to eosinophil influx. J Allergy Clin Immunol 86:466-472
9. Lippert U, Artuc M, Grützkau A, Babina M, Guhl S, Haase I et al. (2004) Human skin mast cells express H2 and H4, but not H3 receptors. J Invest Dermatol 123:116-123
10. Marshall GD Jr (2000) Therapeutic options in allergic diseases: antihistamines as systemic antiallergic agents. J Allergy Clin Immunol 106:S303-9
11. Michel L, De Vos C, Rihoux J-P, Burtin C, Benveniste J, Dubertret L (1988) Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin. J Allergy Clin Immunol 82:101-109
12. Michel L, Murrieta-Aguttes M, Jean-Louis F, Levy D, Dubertret L (2000) Humoral and cellular responses to histamine and pollen allergen in a skin chamber model: effect of mizolastine. Ann Allergy Asthma Immunol 85:64-69
13. Nielsen PN, Skov PS, Poulsen LK, Schmelz M, Petersen LJ (2001) Cetrizine inhibits skin reactions but not mediator release in immediate and developing late-phase allergic cutaneous reactions. A double-blind, placebo-controlled study. Clin Exp Allergy 31:1378-1384
14. Okayama Y, Benyon RC, Lowman MA, Church M (1994) In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin. Allergy 49:246-253
15. Weller K, Maurer M (2009) Desloratadine inhibits human skin mast cell activation and histamine release. J Invest Dermatol 129: 2723-2726
16. Yamada N, Funayama K (1998) Inhibitory effects of mizolastine on the release of mediators and antagonistic effects against mediators. Jpn Pharmacol Ther 26(Suppl):131-138 (Pubitemid 28471032)
17. Zampeli E, Tiligada E (2009) The role of histamine H4 receptor in immune and inflammatory disorders. Br J Pharmacol 157:24-33